Description
Gel for prevention and coadjuvant treatment of injuries caused by papillomavirus (HPV).
Create a defensive barrier that prevents the risk of integration of HPV and the formation of new injuries. It assists in the re-epitelization of the injuries already present. Stimulates regeneration of vaginal microbiota.
Indicated for:
control and help to re-epite the cervical transformation zone to prevent the risk of injury (LSIL) caused by HPV;
the coadjuvant treatment of intraepitelial injuries caused by HPV;
repair and help to summarize the lesions of the cervical-vaginal mucosa;
treat the dryness of the cervical-vaginal mucosa;
rebalance the vaginal microbiota;
improve vaginal health;
create conditions for rapid healing of injuries caused by rubbing due to burning or itching;
form a protective film that quickly reduces the discomfort, creating the conditions suitable to promote the natural process of scarring.
It promotes sexual intercourse. Compatible with the use of condom.
Formula tested under gynecological control.
No perfume. pH 5

Mode of use
The duration of treatment is 6 months, with the possibility of further extending the period according to the prescription. It is important to complete the entire treatment cycle to obtain the expected results. It is recommended to start treatment after the menstrual cycle.
First month: apply a cannula per day for 21 consecutive days, then suspend treatment in the next 7 days.
Later months (second to sixth): apply a cannula to alternate days for 21 days.
Apply Papilocare preferably before sleeping.
Introduce the cannula into the vagina and exert pressure to release its content. Then extract the cannula from the vagina keeping it pressed so that it does not rehabilitate the produced product.

Warnings
Keep out of reach of children. In case of pregnancy consult your doctor. Remove the cannules that are open or broken. Throw the cannula once used. Do not reuse a cannula already used or share it with other patients.
Do not use in case of hypersensitivity known to one of its components. If after application you experience discomfort, suspend the use of the product and consult a doctor. Data on the use of Papilocare with vaginal contraceptives are not available, so we do not recommend the use of Papilocare to women who are using this type of contraceptives. In case of pregnancy, consult your doctor before using Papilocare and use it under strict medical supervision.
Papilocare has a good safety profile and no serious adverse reactions have been observed. The only adverse reaction is post-application irritation.

Conservation
Store at temperature between 22°C and 25°C.

Format
21 single-dose cannulas of 5 ml.

Cod. 010/056